Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohamed A Adam

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Annals of Surgical Oncology|November 13, 2021
ASO Author Reflections: An Objective Hospital Volume Threshold for Minimally Invasive PancreaticoduodenectomyPatricia C Conroy, Adnan Alseidi, Mohamed A Adam
World Journal of Surgical Oncology|November 6, 2019
Overcoming a travel burden to high-volume centers for treatment of retroperitoneal sarcomas is associated with improved survivalRobin Schmitz, Mohamed A Adam, Dan G Blazer
Annals of Surgical Oncology|July 26, 2022
ASO Author Reflections: Neoadjuvant Therapy for Nonpancreatic Periampullary AdenocarcinomaMohamed A Adam, Alexa C Glencer, Amir H Zureikat
Annals of Surgical Oncology|April 3, 2024
Reply to: Letter to Editor Regarding Article "A Machine Learning Approach to Predict Postoperative Pancreatic Fistula after Pancreaticoduodenectomy Using Only Preoperatively Known Data" by Yang, Yanfei et alAmir Ashraf Ganjouei, Jane Wang, Adnan Alseidi, et al.
World Journal of Surgery|January 22, 2016
Patterns of Use and Short-Term Outcomes of Minimally Invasive Surgery for Malignant Pheochromocytoma: A Population-Level Study: ReplyPaolo Goffredo, Mohamed A Adam, Julie Ann Sosa, et al.
Annals of Surgery|January 6, 2018
Response: "Recognizing Implicit Bias, Not Proteomics, Is the Next Step in Mitigating Disparities in Surgical Care"Megan C Turner, Mohamed A Adam, Christopher R Mantyh, et al.
Journal of Surgical Oncology|January 11, 2020
Impact of minimally invasive gastrectomy on use of and time to adjuvant chemotherapy for gastric adenocarcinomaNorma E Farrow, Kyle W Freischlag, Mohamed A Adam, et al.
Annals of Surgical Oncology|June 2, 2023
ASO Author Reflections: Augmenting Clinical Decision-Making Around Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Through Traditional and Machine Learning AlgorithmsAnya L Greenberg, David L Bartlett, Haroon M Choudry, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 12, 2016
Intensity-Modulated Radiation Therapy Is Not Associated with Perioperative or Survival Benefit over 3D-Conformal Radiotherapy for Rectal CancerZhifei Sun, Mohamed A Adam, Jina Kim, et al.
Surgery|March 25, 2019
Neoadjuvant chemoradiation followed by transanal local excision for T2 rectal cancer confers equivalent survival benefit as traditional transabdominal resectionOliver K Jawitz, Mohamed A Adam, Megan C Turner, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Annals of Surgical Oncology|November 13, 2021
ASO Author Reflections: An Objective Hospital Volume Threshold for Minimally Invasive PancreaticoduodenectomyPatricia C Conroy, Adnan Alseidi, Mohamed A Adam
World Journal of Surgical Oncology|November 6, 2019
Overcoming a travel burden to high-volume centers for treatment of retroperitoneal sarcomas is associated with improved survivalRobin Schmitz, Mohamed A Adam, Dan G Blazer
Annals of Surgical Oncology|July 26, 2022
ASO Author Reflections: Neoadjuvant Therapy for Nonpancreatic Periampullary AdenocarcinomaMohamed A Adam, Alexa C Glencer, Amir H Zureikat
Annals of Surgical Oncology|April 3, 2024
Reply to: Letter to Editor Regarding Article "A Machine Learning Approach to Predict Postoperative Pancreatic Fistula after Pancreaticoduodenectomy Using Only Preoperatively Known Data" by Yang, Yanfei et alAmir Ashraf Ganjouei, Jane Wang, Adnan Alseidi, et al.
World Journal of Surgery|January 22, 2016
Patterns of Use and Short-Term Outcomes of Minimally Invasive Surgery for Malignant Pheochromocytoma: A Population-Level Study: ReplyPaolo Goffredo, Mohamed A Adam, Julie Ann Sosa, et al.
Annals of Surgery|January 6, 2018
Response: "Recognizing Implicit Bias, Not Proteomics, Is the Next Step in Mitigating Disparities in Surgical Care"Megan C Turner, Mohamed A Adam, Christopher R Mantyh, et al.
Journal of Surgical Oncology|January 11, 2020
Impact of minimally invasive gastrectomy on use of and time to adjuvant chemotherapy for gastric adenocarcinomaNorma E Farrow, Kyle W Freischlag, Mohamed A Adam, et al.
Annals of Surgical Oncology|June 2, 2023
ASO Author Reflections: Augmenting Clinical Decision-Making Around Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Through Traditional and Machine Learning AlgorithmsAnya L Greenberg, David L Bartlett, Haroon M Choudry, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 12, 2016
Intensity-Modulated Radiation Therapy Is Not Associated with Perioperative or Survival Benefit over 3D-Conformal Radiotherapy for Rectal CancerZhifei Sun, Mohamed A Adam, Jina Kim, et al.
Surgery|March 25, 2019
Neoadjuvant chemoradiation followed by transanal local excision for T2 rectal cancer confers equivalent survival benefit as traditional transabdominal resectionOliver K Jawitz, Mohamed A Adam, Megan C Turner, et al.
Pageof 8